Results 41 to 50 of about 921,366 (160)

Targeting adrenergic receptors to mitigate invariant natural killer T cells-induced acute liver injury

open access: yesiScience, 2023
Summary: Invariant Natural Killer T (iNKT) cell activation by α-galactosylceramide (αGC) potentiates cytotoxic immune responses against tumors. However, αGC-induced liver injury is a limiting factor for iNKT-based immunotherapy.
Michelangelo Bauwelz Gonzatti   +7 more
doaj   +1 more source

Mechanisms of NKT cell–based antibacterial immunity in response to exogenous α-galactosylceramide activation.

open access: yes, 2014
α-galactosylceramide (α-GalCer) presented by respiratory DCs in the context of CD1d activates pulmonary NKT cells to produce IFN-γ and IL-17, which in turn activate macrophages, neutrophils, and possibly NK cells and epithelial cells. Since NKT cells can
Stoyan Ivanov (340915)   +2 more
core   +1 more source

Synthesis of NBD-α-galactosylceramide and Its Immunologic Properties

open access: yes, 2016
A representative α-galactosylceramide (α-GalCer), KRN7000, can activate NKT cells through CD1d molecules, which play an essential role in the generation of the strong antitumor activity of KRN7000.
Teruyuki Sakai (2435098)   +2 more
core   +1 more source

Role of α-Galactosylceramide-activated Vα14 Natural Killer T Cells in the Regulation of Allergic Diseases [PDF]

open access: yes, 2007
Vα14 natural killer T (NKT) cells produce large amounts of both IL-4 and IFN-γ upon stimulation with a ligend, α-galactosylceramide (α-GalCer), and play a crucial role in various immune responses, including allergic reactions.
Chiaki Iwamura   +3 more
core   +1 more source

Superior Protection against Malaria and Melanoma Metastases by a C-glycoside Analogue of the Natural Killer T Cell Ligand α-Galactosylceramide [PDF]

open access: yes, 2003
α-Galactosylceramide (α-GalCer) is a glycolipid that stimulates natural killer T cells to produce both T helper (Th) 1 and Th2 cytokines. This property enables α-GalCer to ameliorate a wide variety of infectious, neoplastic, and autoimmune diseases ...
Schmieg, John   +3 more
core   +2 more sources

Unraveling A4GALT Mechanism and Its Modulation With Adamantyl‐Galactosylceramide Analogues: Advancing Fabry Disease Therapeutic Strategies

open access: yesAngewandte Chemie International Edition, Volume 65, Issue 41, 5 October 2026.
A 310‐helix‐mediated conformational switch promotes a front‐face SNi‐like catalysis by human A4GALT. Mechanism‐guided design identifies AdaGalCer as a selective modulator of globotriaosylceramide (Gb3) biosynthesis, opening a clear route toward new Fabry disease therapeutics.
Nicky de Koster   +13 more
wiley   +1 more source

Social disruption stress exacerbates alpha-galactosylceramide-induced hepatitis in mice [PDF]

open access: yes, 2005
Objective: Psychosocial stress has been suggested as a possible aggravating factor in liver diseases, however, the underlying mechanism has yet to be clarified.
Chida, Y, Kubo, C, Sonoda, J, Sudo, N
core  

Expedient Synthesis of the α-C-Glycoside Analogue of the Immunostimulant Galactosylceramide (KRN7000)

open access: yes, 2016
Key reactions in a concise synthesis of an α-C-galactosylceramide analogue of KRN7000 include a diastereoselective alkenylalane addition to an N-tert-butanesulfinyl imine and the use of an epoxidation/carbamate ring opening sequence to install the ...
Peter Wipf (134666)   +1 more
core   +1 more source

Developing an On‐Resin Synthesis of α‐Galactosylceramide‐Peptide Conjugate Vaccines

open access: yesChemistryEurope
The covalent attachment of peptide antigens to the NKT cell agonist, α‐galactosylceramide (αGalCer), generates self‐adjuvanting vaccines that prevent and/or eliminate disease in animal models of cancer and infectious disease.
Dr. Michael A. Meijlink   +10 more
doaj   +1 more source

Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection. [PDF]

open access: yesPLoS ONE, 2012
α-Galactosylceramide (α-GalCer) is the prototypical lipid ligand for invariant NKT cells. Recent studies have proposed that α-GalCer is an effective adjuvant in vaccination against a range of immune challenges, however its mechanism of action has not ...
Emma C Reilly   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy